Connect with us

legalization

Wasted Weed: Canada’s Disposal of 3.7 Million Pounds of Cannabis Since 2018

Published

on

bipolar-disorder

Fact check: Is legalization hurting teen mental health?

Published

on

By


If you read this January 10 Wall Street Journal piece, you might conclude that a wave of cannabis-induced psychosis among teenagers is sweeping the country. The story highlights research on the correlation between cannabis use and conditions like schizophrenia and bipolar disorder. It suggests access to higher-potency cannabis is leading to ever-increasing rates of psychosis in teens. 

But the actual data paints a different picture. Population studies of over 63 million people show that rates of psychosis do not go up amid legalization. Teen use rates of marijuana are actually going down. And our best science suggests that genetic factors—rather than cannabis use—are to blame for the correlation between cannabis and psychosis. 

Can cannabis really induce life-long psychotic conditions—or is this yet another example of confusing correlation with causation, a common source of “reefer madness?”

The research on cannabis and psychosis is nuanced, but it definitely shows a strong correlation—as opposed to a causation—between the two. For instance, the data is clear that acute cannabis exposure can cause you to see vivid colors, or mis-hear sounds, or get anxious. These experiences have been described as transitory “psychosis-like” episodes—particularly for occasional users

Confusing correlation with causation

With that in mind, it might not be surprising that when teens who use cannabis develop permanent psychosis-related conditions, their doctors and loved ones jump to the conclusion that cannabis caused the shift. There are numerous stories of teens who used cannabis and were subsequently diagnosed with these challenging, life-long conditions. Statistically, individuals who use cannabis are more likely to have bipolar disorder or schizophrenia than the general population

But scientists have long struggled with the question of whether cannabis use actually causes these conditions—or if a third factor drives both. Based on cases where these conditions emerge after cannabis use, researchers estimate that cannabis-induced psychosis occurs in .0027% of consumers. But even at this exceptionally rare rate, correlative studies can’t prove whether cannabis is the cause of psychosis or not. 

There are many ways to interpret the data that associate cannabis with psychosis. For example, individuals with psychosis conditions could be more likely to use cannabis in the first place, as a form of self-medication. If this were true, it would result in the same strong correlation.

Related

Did cannabis legalization improve a state’s mental health?

Other correlates: Alcohol, tobacco

Cannabis certainly isn’t the only factor linked with psychosis, even though it receives more publicity. Studies have found many things correlate with higher risk of psychosis, including the use of any recreational substance, like alcohol and tobacco. These substances are used at similar rates by schizophrenics as cannabis, and show similar statistical increases in psychosis risk. No one is debating, however, whether we should prohibit these substances. 

Shop highly rated dispensaries near you

Showing you dispensaries near

See all dispensaries

Life stressors

Stress also frequently correlates to psychosis. The stress associated with an event like a teenager leaving home to begin college can trigger an initial psychotic episode.

One review study found that the strongest factors correlated with developing lasting psychosis include a) living in an urban area and b) being an ethnic minority. Since cannabis is often used to combat stress, it’s possible that people who are stressed out enough to develop psychosis are more likely to seek out cannabis.

Spice, K-2, and designer drugs 

And lastly, studies that associate cannabis with psychosis don’t specify which specific cannabinoids are at play. For example, businesses like head shops and truck stops sell unlicensed, unregulated—and often illegal—synthetic cannabinoids (THC-O, THC-P, HHC, etc.) that can be hundreds of times more powerful than THC alone. 

The use of dangerous synthetics like Spice prevails in states that lack access to legal botanical THC. Athletic and military THC testing regimes also induce players and servicemembers to seek out novel, dangerous synthetics that won’t show up in a drug test.

Data suggests that using synthetic cannabinoids can induce more symptoms of psychosis than natural cannabis.

cannabis use survey, youth cannabis consumption
(Iuliia Kanivets, CSA-Printstock/iStock)

Legalization isn’t increasing teen use

Some research also suggests that cannabis use among teenagers in particular has a strong correlation with a subsequent diagnosis of a psychosis-related condition. This could mean that teens are particularly vulnerable to cannabis’ effects. But it could also point towards the fact that conditions like bipolar disorder and schizophrenia are most commonly identified and diagnosed while patients are in their twenties, while cannabis use usually begins during teenage years. It is possible that individuals with these conditions would be more likely to self-medicate with cannabis; since this typically occurs before their diagnosis, doctors and scientists would assume that cannabis caused the psychosis-like condition.

While many prohibitionists would use any potential for teen psychosis as a reason to limit cannabis legalization, it’s important to note that rates of teen cannabis use are going down, not up, as states legalize cannabis. Street dealers do not check ID, but legitimate dispensaries do. This means that legalization tends to limit teen access, rather than increasing it. 

Related

Cannabis Legalization and Teenage Use: What Do Studies Tell Us?

Psychosis rates *do not* increase with cannabis legalization 

Fortunately, scientists dig deeper than simple correlative studies. For instance, they look at the rates of psychosis in places where cannabis is more available. If cannabis’ prevalence causes psychosis, it would follow that as cannabis access increases, we would see rising rates of psychosis. 

While legalization does increase rates of other conditions that are directly triggered by cannabis use, such as cannabinoid hyperemesis syndrome, the studies that examine psychosis rates have had very mixed results. 

The WSJ article mentioned earlier in this article cites a small Danish study that examined data collected from 6,788 people in 11 locations throughout Europe and Brazil. None had access to tested, legal cannabis.

While it did find a link between access to high-potency cannabis and psychosis, a much larger US study involving over 63 million people found that access to medical or recreational cannabis had no impact on psychosis rates at all. If we were seeing a dramatic wave of teen psychosis in the US, as suggested in the recent WSJ piece, that shift should be reflected in this large-scale population study. 

Related

Amid legalization, teen hospitalizations for pot down 50%, CDC finds

Genetics may drive cannabis use as well as mental health outcomes 

Psychosis rates haven’t skyrocketed with the recent increase in legal cannabis access, so why do we see any correlation between the two? 

Beyond the possibilities suggested above, genetics may play a key role. Scientists have found data that points to underlying genes that predispose someone to both psychosis and cannabis-use disorder. (Doctors diagnose cannabis-use disorder when someone experiences negative effects from cannabis use, wants to stop using it, but cannot bring themselves to quit despite repeated efforts.)

Research reviews have found that an individual who has genetics correlated with cannabis-use disorder may be more likely to develop schizophrenia, whether or not they actually ever used cannabis. This suggests that genetics, rather than cannabis, is to blame. 

One the best-designed studies just came out. In January, researchers published a rare study of more than 4,000 identical twins over time. One twin used weed while the other didn’t, and researchers tracked them for 27 years. Weed use did not predict mental health outcomes.

“Cannabis consumption did not predict within-pair differences in psychoticism.”

Zellers, 2024, Journal of Psychopathology and Clinical Science

“Cannabis consumption did not predict within-pair differences in psychoticism,” the researchers concluded.

There’s a big takeaway here: If you have a family history of mental illness, and are increasing your cannabis use, you might want to re-evaluate your habits.

The data also supports maintaining 21 as the legal appropriate age for cannabis consumption; that’s typically towards the back end of when congenital mental illness may crop up in an individual. 

While more research may shift our understanding of these issues, the current data does not suggest that cannabis use is a strong causal factor for chronic mental illness. Still, given cannabis’ ability to cause visual effects or strange thoughts, THC may be best avoided by at-risk patients. At the same time, doctors are actively evaluating whether the cannabinoid CBD can treat mental illnesses. 

As always, consult with a cannabis-specializing doctor before beginning medical use of cannabis to treat your symptoms.  



Source link

Continue Reading

adult-use legalization

Which states will legalize marijuana in 2024?

Published

on

By


While President Biden does not appear keen to champion federal legalization anytime soon, the beginning of 2024 nonetheless finds us at the precipice of a remarkable crossroads: Since Ohio became the 24th state to legalize adult-use marijuana in November, nearly half of all US states have gone green. Furthermore, 38 states have legalized medical marijuana. And when it comes to the number of Americans who live in states with rec cannabis, we’ve officially crossed the halfway point.

So whaddaya say, Leafly Nation? Let’s keep the ball rolling!

In 2024, several more states could write bills—or send measures to voters—to legalize adult-use cannabis or medical marijuana, sending us over the hump.

Read on to learn which states we’ve got our eyes on, the specifics of the measures themselves, and where these various campaigns currently stand.

Florida

A legal battle over the fate of a legalization voter initiative is underway in Florida, where the organization Smart & Safe Florida has raised $40 million for a campaign to put a measure on the 2024 ballot; virtually all of the funds have come from the MMJ dispensary franchise Truelieve. The measure is sparse on specifics but legalizes holding 3 ounces of marijuana, and up to 5 grams of concentrate. 

Opponents of the ballot measure believe it violates a single-subject requirement for such initiatives. The state Supreme Court heard arguments on the case in November, and must give it a thumbs up or down by April 1. Stay tuned!

Related

30 weed predictions very likely to come true in 2024

Hawai’i

Fortunately, Hawaii has a pro-legalization governor. Unfortunately, lawmakers in the state House recently kneecapped the legalization bill SB 669, even though the state Senate passed it with near-unanimous support. Legislative sessions last two years in Hawaii, and advocates remain somewhat hopeful they can revive SB 669 in 2024. In its current form, the bill would allow medical dispensaries to become rec stores, add both a 10% sales tax and a 10% excise tax, legalize possession of 1 ounce, and weed gardening, among other provisions.

Idaho

Over in Idaho, which has some of the most draconian marijuana laws in the country, activists with Kind Idaho have until next April to gather 63,000 signatures to put a medical marijuana legalization measure on the 2024 ballot. The measure legalizes possession of four ounces, legalizes weed gardening, adds a 4% excise tax, and allows for an extensive list of qualifying conditions.

Shop highly rated dispensaries near you

Showing you dispensaries near

See all dispensaries

Kentucky

Hey, this one doesn’t even require looking into the crystal ball. This March, Gov. Andy Beshear (D) signed medical marijuana into law. The state will accept licenses and get the program set up in 2024; it will launch on January 1, 2025.

Nebraska

Will the third time be the charm? A team of tireless advocates in Nebraska are at it again to put a medical marijuana initiative on the 2024 ballot. They’ve got until July to gather 87,000 signatures for two separate measures; one of which adds legal protections for patients, and the other requires the state to set up regulations for a medical program. Then, if they meet signature requirements, activists will likely have to tangle (again) with the state’s remarkably prohibitionist legislature and 17th-century governor. Bon chance, Nebraska!

Related

New Year, New Laws: Weed workers’ rights kick in, and more

Pennsylvania

Even though Pennsylvania boasts one of the most vocal pro-legalization senators in the country, and a pro-legalization governor, and even though all but one of its neighbors have legalized, lawmakers in the Keystone State have been unable to get a bill over the finish line. The long and short of it? Enough Republicans won’t budge to get a bill through the state legislature, and Democrats can’t unite behind a single proposal. Hopefully, 2024 is the year PA can break the impasse and unite with its neighbors in marijuana matrimony.

South Dakota

Legalization advocates in South Dakota won’t take “no” for an answer. In 2020, the Mount Rushmore State voted 52-48 to legalize adult-use cannabis and medical marijuana, but the state’s prohibitionist (and arguably anti-democratic) governor Kristi Noem (R) succeeded in getting the adult-use measure overthrown. Then, a separate measure failed at the ballot box in 2022. Now, two separate groups of activists are gathering signatures to put separate legalization measures on the 2024 ballot.

Did we miss a state? Leave a comment below and let us know. Stay tuned to Leafly News for legalization updates in all of these states as we move toward the 2024 election!



Source link

Continue Reading

adult-use cannabis

Nevada Increases Legal Marijuana Possession Limits

Published

on

By


Summary: In Nevada, new marijuana possession limits are set to take effect from January 1st, allowing adults aged 21 and older to purchase up to 2.5 ounces of cannabis flower and/or up to one-quarter of an ounce of concentrates from licensed retailers. This change comes as a result of legislation signed by Republican Gov. Joe Lombardo, increasing the legal purchase and possession limits.

Nevada’s Laws Evolve: Higher Marijuana Possession Limits Starting January

The new legislation, SB 277, signed into law by Governor Joe Lombardo in June, marks a significant change in Nevada’s cannabis regulations. Previously, the law limited possession to one ounce of flower and one-eighth of an ounce of concentrates. The updated law now permits adults to legally purchase and possess up to 2.5 ounces of cannabis flower and up to one-quarter of an ounce of concentrates.

This change reflects Nevada’s evolving stance on cannabis use and regulation. In 2016, Nevada voters approved a statewide ballot initiative legalizing the adult-use cannabis market, following the approval of medical cannabis production and distribution in 2000. The new possession limits are part of a broader effort to regulate and normalize cannabis use in the state.

Additionally, the law includes provisions allowing licensed medical dispensaries to begin serving non-patients starting January 1st. This expansion of access is expected to further integrate cannabis into Nevada’s legal and commercial landscape.

Source: NORML


Subscribe to our weekly newsletter:

We hope you enjoyed this news update. Check back with us daily to see what’s going on in the world of cannabis and psychedelics. And make sure to subscribe to our weekly newsletter, the Cannadelics Sunday Edition with a the best stories of the week:

.

.

AI Disclaimer: This news update was created using a AI tools. PsychePen is an AI author who is constantly improving. We appreciate your kindness and understanding as PsychePen continues to learn and develop. Please note that the provided information is derived from various sources and should not be considered as legal, financial, or medical advice.



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media